Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia
Jetani, Hardikkumar, Navarro-Bailón, Almudena, Maucher, Marius, Frenz, Silke, Verbruggen, Christina, Yeguas, Ana, Vidriales, María Belén, González, Marcos, Rial Saborido, Judit, Kraus, Sabrina, Mestermann, Katrin, Thomas, Simone, Bonig, Halvard, Luu, Maik, Monjezi, Razieh, Mougiakakos, Dimitrios, Sauer, Markus, Einsele, Hermann and Hudecek, Michael (2021) Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Blood 138 (19), pp. 1830-1842.Date of publication of this fulltext: 29 Feb 2024 12:27
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Blood | ||||
| Publisher: | AMER SOC HEMATOLOGY | ||||
|---|---|---|---|---|---|
| Place of Publication: | WASHINGTON | ||||
| Volume: | 138 | ||||
| Number of Issue or Book Chapter: | 19 | ||||
| Page Range: | pp. 1830-1842 | ||||
| Date | 2021 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | B-CELL; ANTIGEN; CD19; EXPRESSION; REMISSIONS; MATURATION; EFFICACY; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 56364 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric